Endra Life Sciences earnings were -$5.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest NDRA earnings report on Jun 30, 2026 announced Q2 2026 earnings of $159.9k, down 112.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NDRA reported annual earnings of -$7.0M, with -38.9% growth. The next NDRA earnings date is Nov 13, 2026.
Endra Life Sciences Earnings Reports & History FAQ
What were Endra Life Sciences's earnings last quarter?
On NDRA's earnings call on Aug 13, 2026, Endra Life Sciences (NASDAQ: NDRA) reported Q2 2026 earnings per share (EPS) of $0.12, up 107.02% year over year. Total NDRA earnings for the quarter were $159.94 thousand. In the same quarter last year, Endra Life Sciences's earnings per share (EPS) was -$1.71.
The next NDRA earnings date is Nov 13, 2026. Add NDRA to your watchlist to be reminded of Endra Life Sciences's next earnings date.
Is Endra Life Sciences profitable or losing money?
As of the last Endra Life Sciences earnings report, Endra Life Sciences is currently losing money. Endra Life Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$5.92 million, a 32.5% decrease year over year.
What was NDRA's earnings growth in the past year?
As of Endra Life Sciences's earnings date in Aug 13, 2026, Endra Life Sciences's earnings has grown year over year. NDRA earnings in the past year totalled -$5.92 million.
What are Endra Life Sciences's earnings expectations?
The current EPS estimate for Endra Life Sciences's earnings report in Nov 13, 2026 is -$0.84.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.